176 related articles for article (PubMed ID: 26615555)
1. Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study.
Lee DH; Kim SH; Im SA; Oh DY; Kim TY; Han JK
Eur Radiol; 2016 Aug; 26(8):2771-8. PubMed ID: 26615555
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI and
Yoo J; Kim SH; Han JK
Eur Radiol; 2020 Mar; 30(3):1634-1643. PubMed ID: 31781931
[TBL] [Abstract][Full Text] [Related]
3. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer.
Lee DH; Kim SH; Joo I; Hur BY; Han JK
Eur J Radiol; 2016 Jun; 85(6):1085-91. PubMed ID: 27161056
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
Pinker K; Andrzejewski P; Baltzer P; Polanec SH; Sturdza A; Georg D; Helbich TH; Karanikas G; Grimm C; Polterauer S; Poetter R; Wadsak W; Mitterhauser M; Georg P
PLoS One; 2016; 11(5):e0155333. PubMed ID: 27167829
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with
Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X
Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer.
Lee DH; Kim SH; Lee SM; Han JK
Korean J Radiol; 2019 Apr; 20(4):589-598. PubMed ID: 30887741
[TBL] [Abstract][Full Text] [Related]
7. Is
Sugimura K; Miyata H; Yano M; Yanagimoto Y; Ho MJ; Kobayashi S; Takahashi H; Omori T; Ohue M; Sakon M
Gen Thorac Cardiovasc Surg; 2017 Aug; 65(8):455-462. PubMed ID: 28585161
[TBL] [Abstract][Full Text] [Related]
8. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
9. Added value of [
Yoon I; Bae JS; Yoo J; Lee DH; Kim SH
Eur Radiol; 2021 Oct; 31(10):7834-7844. PubMed ID: 33768290
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
[TBL] [Abstract][Full Text] [Related]
11. Can combined 18F-FDG-PET and dynamic contrast-enhanced MRI predict behavior of desmoid tumors in patients with familial adenomatous polyposis?
Bhandari S; Taylor NJ; Sinha A; Sonoda L; Sanghera B; Wong WL; Goh V; Clark SK
Dis Colon Rectum; 2012 Oct; 55(10):1032-7. PubMed ID: 22965401
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI versus 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy.
Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Aoyama N; Onishi Y; Sugimura K
AJR Am J Roentgenol; 2012 Jan; 198(1):75-82. PubMed ID: 22194481
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience.
Hectors SJ; Wagner M; Besa C; Huang W; Taouli B
Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI.
Herrmann K; Bundschuh RA; Rosenberg R; Schmidt S; Praus C; Souvatzoglou M; Becker K; Schuster T; Essler M; Wieder HA; Friess H; Ziegler SI; Schwaiger M; Krause BJ
Mol Imaging Biol; 2011 Oct; 13(5):1011-9. PubMed ID: 20936364
[TBL] [Abstract][Full Text] [Related]
15. The Predictive and Prognostic Value of Early Metabolic Response Assessed by Positron Emission Tomography in Advanced Gastric Cancer Treated with Chemotherapy.
Wang C; Guo W; Zhou M; Zhu X; Ji D; Li W; Liu X; Tao Z; Zhang X; Zhang Y; Li J
Clin Cancer Res; 2016 Apr; 22(7):1603-10. PubMed ID: 26607599
[TBL] [Abstract][Full Text] [Related]
16. Grading of cerebral glioma with multiparametric MR imaging and 18F-FDG-PET: concordance and accuracy.
Yoon JH; Kim JH; Kang WJ; Sohn CH; Choi SH; Yun TJ; Eun Y; Song YS; Chang KH
Eur Radiol; 2014 Feb; 24(2):380-9. PubMed ID: 24078054
[TBL] [Abstract][Full Text] [Related]
17. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
[TBL] [Abstract][Full Text] [Related]
18. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
20. MRI and FDG-PET for assessment of response to neoadjuvant chemotherapy in locally advanced rectal cancer.
Aiba T; Uehara K; Nihashi T; Tsuzuki T; Yatsuya H; Yoshioka Y; Kato K; Nagino M
Ann Surg Oncol; 2014 Jun; 21(6):1801-8. PubMed ID: 24531702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
